EN
TR
After the end of IP law protection for originator drug manufacturers, generic drug…
The Commission specified precisely that a patent-related settlement agreement between…
Also, prospective litigation costs would negatively affect the society, as pharmaceutical…
The General Court ruled, for the first time, a pay-for-delay agreement for Lundbeck…
Even if the coordination between originator and generic drug manufacturers by making…
The protection provided by IP rights ministers to the continuation of innovation…
The conservation of competitive markets is one of the best effective ways to hamper…
